The United States has suspended HIV aid to South Africa, a move that threatens years of progress in the fight against the disease. The decision, announced late last night, cuts off billions of rand in funding for antiretroviral drugs and prevention programmes. For the millions of South Africans living with HIV, this is not a diplomatic squabble. It is a matter of life and death.
Activists and health experts are now turning to Britain. They argue that the UK, as a leading Commonwealth nation with a proud tradition of global health investment, must step into the breach. The call is not just for charity but for solidarity among allies. The Commonwealth, they say, offers a ready-made network of nations that can pool resources and coordinate efforts.
The timing could not be worse. South Africa has the largest HIV epidemic in the world, with over 7.5 million people living with the virus. The US President's Emergency Plan for AIDS Relief (PEPFAR) has been a cornerstone of the response, providing roughly 17% of the country's HIV budget. Without it, treatment disruptions are inevitable. The South African government has vowed to find savings, but its economy is fragile, and the gap is vast.
Britain has its own pressures. The NHS is stretched, and austerity has bitten deep. But foreign aid budgets, while debated, have long been a source of national pride. The UK was the first G7 nation to meet the UN target of spending 0.7% of gross national income on aid, though that commitment was recently cut to 0.5%. Now, campaigners say, is the time to restore it and to lead.
"This is a test of our values," said Dr. Thandi Mokoena, a Johannesburg-based public health specialist. "If Britain does not act, people will die. It is that simple." The call is echoed by British MPs from all parties, who see an opportunity to reassert the UK's global role post-Brexit. The Commonwealth, with its shared language and institutions, is a natural vehicle.
But the path is not straightforward. The UK's aid budget is already oversubscribed, and any new commitment would require either a Treasury u-turn or a reprioritisation of existing funds. There are also political hurdles. The US withdrawal reflects a broader shift towards isolationism under President Trump, and there is no guarantee that Britain's overtures would be welcomed in Washington.
Nevertheless, the moral imperative is clear. For years, the global community has fought to turn the tide on HIV. The gains have been remarkable: fewer deaths, fewer infections, more people on treatment. To let that progress unravel would be a tragedy. Britain, with its history of leadership on global health, has a duty to respond.
Let us be blunt: this is not about charity. It is about justice. The Commonwealth was built on a foundation of mutual obligation. If that means anything, it means standing with South Africa now. The British government must move quickly to convene a summit of Commonwealth health ministers and to pledge new funding. Delay is not an option.
For the patients in Soweto and Durban, for the nurses and community health workers, the clock is ticking. Britain must decide whether it will be a bystander or a lifeline.